Literature DB >> 30072275

Guillain-Barré syndrome associated with Zika virus infection: Analysis of a cohort from the region of northern Veracruz in 2016-2017.

L Del Carpio-Orantes1, K G Peniche Moguel2, J S Sánchez Díaz2, M Del R Pola-Ramirez3, M Del P Mata Miranda3, S García-Méndez4, M A Perfecto-Arroyo5, I Solís-Sánchez5, B M Trujillo-Ortega5, E E González-Flores5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30072275     DOI： 10.1016/j.nrl.2018.05.002

Source DB:  PubMed          Journal:  Neurologia (Engl Ed)        ISSN： 2173-5808


× No keyword cloud information.
  4 in total

1.  Guillain-Barré syndrome, from the search for Zika to the discovery of asymptomatic campylobacteriosis as a risk factor for neurological syndromes in Veracruz, Mexico.

Authors:  Luis Del Carpio-Orantes
Journal:  Brain Circ       Date:  2022-09-21

2.  Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: A living systematic review.

Authors:  Michel Jacques Counotte; Kaspar Walter Meili; Katayoun Taghavi; Guilherme Calvet; James Sejvar; Nicola Low
Journal:  F1000Res       Date:  2019-08-14

3.  Guillain-Barré syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype.

Authors:  Sonja E Leonhard; Cristiane C Bresani-Salvi; Joanna D Lyra Batista; Sergio Cunha; Bart C Jacobs; Maria Lucia Brito Ferreira; Maria de Fatima P Militão de Albuquerque
Journal:  PLoS Negl Trop Dis       Date:  2020-04-27

4.  Zika Virus infection and Guillain-Barré syndrome in Northeastern Mexico: A case-control study.

Authors:  Fernando Gongora-Rivera; Israel Grijalva; Adrian Infante-Valenzuela; Carlos Cámara-Lemarroy; Elvira Garza-González; Martin Paredes-Cruz; Concepción Grajales-Muñiz; José Guerrero-Cantera; Ignacio Vargas-Ramos; Jesus Soares; Joseph Y Abrams; Ashley R Styczynski; Adrián Camacho-Ortiz; Margarita E Villarino; Ermias D Belay; Lawrence B Schonberger; James J Sejvar
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.